{"database": "openregs", "table": "documents", "rows": [["FDA-2019-N-5711-0035", "FDA", "FDA-2019-N-5711", "Reference 2 Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs re Importation of Prescription Drugs", "Supporting & Related Material", "Background Material", "2020-01-06T05:00:00Z", 2020, 1, null, null, "2020-01-06T20:46:02Z", null, 0, 0, "090000648420d899"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2019-N-5711-0035"], "units": {}, "query_ms": 108.84944791905582, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}